3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Breast Neoplasms
8
Polycystic Ovary Syndrome
5
Multiple Myeloma
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Colorectal Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Pancreatic Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Venous Thromboembolism
1
Urinary Bladder Neoplasms
1
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Thrombosis
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Rectal Neoplasms
1
Perioperative Inflammatory Response
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurotoxicity Syndromes
1
Interventions
Ifosfamide
2
Doxorubicin
2
Cyclophosphamide
2
tebentafusp
1
selinexor
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pazopanib
1
fludarabine phosphate
1
fludarabine
1
cobimetinib
1
Zoledronic Acid
1
Vemurafenib
1
Topotecan
1
Sunitinib
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Radiation Dose Hypofractionation
1
Proton Therapy
1
Nivolumab
1
Methotrexate
1
Mesna
1
Granulocyte Colony-Stimulating Factor
1
Epirubicin
1
Diathermy
1
Dacarbazine
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Clear Cell
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled